Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):429–436. doi: 10.1097/QAI.0000000000001687

Table 1.

Baseline demographics

Demographic n=139
Age (years), median (IQR) 44 (44-50)
Male, n (%) 110 (79.1%)
Ethnicity, n (%)
 White 64 (46.0%)
 Black 61 (43.9%)
 Hispanic 13 (9.4%)
 Other 1 (0.7%)
Comorbidity, n (%)
 Incidental 88 (63.3%)
 Contributing 35 (25.2%)
 Confounding 16 (11.5%)
Years of education, median (IQR) 13.0 (12.0-15.0)
Weight (kg), median (IQR) 77.7 (70.5-87.8)
Duration of HIV-infection (years), median (IQR) 12.2 (6.3-15.8)
Current CD4+ (cells/μL), median (IQR) 540 (353-698)
CD4+:CD8+ cell count ratio, median (IQR) 0.60 (0.42-0.91)
Nadir CD4+ (cells/μL), median (IQR) 121 (20-237)
Duration of antiretroviral therapy (years), median (IQR) 6.3 (2.6-9.4)
Plasma HIV RNA <50 copies/mL, n (%) 139 (100%)
Prior clinical AIDS, n (%) 55 (39.6%)